首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
A Dose of Reality Major Reality Check When the pain reliever Vioxx was Withdrawn from the market last fall after the announc
A Dose of Reality Major Reality Check When the pain reliever Vioxx was Withdrawn from the market last fall after the announc
admin
2010-08-21
21
问题
A Dose of Reality
Major Reality Check
When the pain reliever Vioxx was Withdrawn from the market last fall after the announcement that it increased patients’ risk of heart attacks and strokes, millions of Americans panicked. The sometimes sensationalized headlines didn’t help. People wondered, "Should I trust my doctor?" "Could a medication that I thought would help me actually kill me?" "Is our drug safety system broken?"
Suddenly, ads for the drug were replaced with ads looking for Vioxx "victims". Law firms across the nation began recruiting anyone who had ever taken the drug as plaintiffs (原告) for class-action (公诉) suits. Merck, the company that developed the drug, could be liable for billions of dollars, making it one of the costliest liability cases ever, No surprise, then, that Merck’s stock plummeted(垂直落下) 40 percent in just six weeks.
But the real cost was even greater. Not only did patients stop taking Vioxx but, doctors say, many people stopped taking their other medicines, too—sometimes putting their health at serious risk.
Vioxx was the first pebble in the pharmaceutical rock slide. Soon, accusations about a spate of other drugs were making headlines, including all COX-2 inhibitors which, like Vioxx, relieve pain. The charges didn’t stop there. The FDA was accused of simply robber-stamping new drugs; drug companies. were blamed for hiding information about unsafe products; .and the efficacy(功效) of clinical trials that did not reveal how large numbers of people would react was questioned. But one question that was rarely asked could determine whether or not pharmaceutical companies continue to develop and produce breakthrough medications that can save or extend lives and help people live without pain. The question: do Americans expect drugs to be risk-free? And, if someone suffers a bad reaction, will lawyers rather than doctors be the first people we call?
Panic over Pills: Overreaction?
During the ten-year period between 1994 and 2004, the FDA approved 321 completely new drugs (this doesn’t include approvals for changes to existing medicines), bringing the total to more than 10,000 drug products on the market. During that same period, eight drugs were withdrawn for reasons of safety, such as the diet drug fenfluramine (fen-phen, associated with heart-valve disease) and the allergy drug Seldane (linked to heart arrhythmias). But the Vioxx recall created a shock wave for the American consumer like no other. Many people had come to depend on their "meds", and they expected them to be safe, too, especially when they cost so much. Prescription drugs account for, some Say, the fastest growing segment (about one- tenth) of all health expenditures, with some specialty drugs costing hundreds of dollars per dose.
"With Vioxx, the real shock and outrage came when there was a suggestion that people in authority may have known about these harmful side effects and not shared them with doctors or the public," says Anne Woodbury, chief health advocate for the Center for Health Transformation, a think tank founded by Newt Gingrich. It made people question their faith in the pharmaceutical industry, federal regulators and physicians—those we trust to make sure our drugs are safe. Before, taking a newly prescribed pill with a slug of water was as routine as brushing your teeth. For many people, this is no longer the case.
People have reason to worry. In clinical trial data submitted to the FDA, Vioxx showed no connection to heart problems. The drug was approved in May 1999. But after Vioxx hit the market and grew in popularity, heart problems were revealed— lots of them. Tens of thousands of people may have been affected, and Merck was accused of hiding that information.
"The system is not perfect," comments Marianne J. Legato, MD, professor of clinical medicine at Columbia University College of Physicians and Surgeons in New York City. "Sometimes a company may not want to show data that are negative till they really know what’s going on. But it’s ridiculous to suggest that they would suppress things willy-nilly, because if a drug is going to cause severe side effects, it’s not in their best interest to hide that."
How Side Effects Emerge
How can dangerous side effects take years, or even decades, to become known? A new drug is first tested on animals. If the results indicate that it’s likely to be both safe and effective, the company applies to the FDA for permission to begin testing it in humans. Human studies have three phases: to evaluate safety, to determine effectiveness, end to verify safety, dosage and effectiveness. Although a trial may extend as long as five years and often includes between 3,0DO and 10,000 people, each participant may only receive the medication for a period of weeks or months. Statistically, rare and dangerous side effects may not emerge until millions of people have used the drug, after FDA approval.
So why don’t we test drugs on more people and for longer periods of time? For one thing, quicker approvals may save lives, as with drugs for AIDS or a vaccine for a newly emerging flu pandemic. Another reason is cost. "It already costs a billion dollars to get a drag from an idea to the market," rays Corr. "If we had to study a million patients before we took a drug to market, there would never be another drug."
Monitoring after Approval
After a drug is approved, it is subject to post-market surveillance(监督). The FDA analyzes reports of "adverse events", or drug side effects, which come from the industry, from ongoing clinical trials and through its Mad Watch program, to which consumers, physicians, pharmacists and other health professionals voluntarily report problems.
Negative reports about a drug that’s on the market can yield crucial new information. "Clinical trials that are negative are, many times, just as important as the trials that show positive results," says Marvin Lipman, MD, chief medical adviser for Consumer Reports. Legislation was introduced in both the House and Senate in October 2004 to establish a registry of all clinical trials and their results. "We are the most regulated industry in the world," rays Corr. "And frankly, that’s how it should be. If there is a problem with a drug, We want to know about it sooner rather than later."
Consumers may know sooner too. In February the FDA announced the creation of an independent Drug Safety Oversight Board to provide expanded and faster drug-safety information to doctors and patients. While there will always be risks, the Public may be better equipped to judge and act on them.
"We still need to be willing to take personal responsibility for assessing the risk-benefit ratio of a medication," says Legato. "Yes, you have to be completely informed to do it. And, yes, it’s complex. But if we don’t do this, ifs like going back to the Middle Ages when there were no risks, except of dying by the age of 26. We have nearly doubled life expectancy since the beginning of the 20th century. That did not happen by accident. Prescription drugs have played a huge role."
How You Can Make Informed Decisions
Since there is no such thing as a pill that is completely safe, including aspirin, consumers have to accept the dichotomy (二分法) that the same medicines that extend and enhance our lives may hurt us; some of them may merely have minor side effects, while others con. be lethal. So how should you and your doctor proceed?
-- Weigh the risks and benefits of any drug. As a smart consumer you must decide whether a drug is "safe enough" for you. The greater the benefit, the more risk you may be willing to take. If your illness is mild and not very bothersome, you may decide that any risk is too big and opt against taking any medication at all. Conversely; if your illness is serious or potentially life threatening, you may even be willing to try an experimental drug with greater risk for serious side effects.
-- Be especially cautious about new drugs. New drugs are inherently risky. So if you’re taking one, monitor yourself carefully. Have your eating and digestive habits changed? Are you feeling unusually tired or conversely agitated(激动的)? Have your breathing patterns or skin color changed? If so, call your doctor immediately, who may tell you to stop taking the drug. How does a consumer know that a drug is new? Ask your doctor or pharmacist.
-- lf you have a choice between two equally effective drugs, choose the one with a longer track record of safety. If you ere taking a drug in the same class as one that, has been recalled, it is prudent to ask your doctor if that drug places you at greater risk.
-- Know if you’re in a high-risk group. Although scientists still don’t know precisely why, certain individuals have bad reactions to a drug or to a particular dose of a drug, while others don’t—taco metabolize drugs differently than women do, for example—be especially vigilant (警惕的) if you are very young, very old or pregnant. Drugs usually aren’t tested on these groups. "I worry the most about the elderly," says Avorn. "They are vastly under-represented in trials of drugs, yet they ere the most likely to be taking the drugs when they ere approved."
-- Ask the right questions. When you get a new prescription, never leave the doctor’s office without a deer understanding of why you’re taking the drug, how to take it, end how you’ll know if it’s working. Even if it makes you a bit uncomfortable, ask. You are responsible for your own health and safety. "If the doctor doesn’t want to answer questions, you should probably find another doctor," says Avorn. After your visit; if you still have questions, call or e-mail the doctor. Use your pharmacist as an expert consultant for any additional concerns you have about the drug or its side effects. You can also call the drag company’s toll-free number for more information, or go to its website.
If you have may concern about a new drag or its side effects, you can ask your doctor or pharmacist questions, or call the drug company for ______.
选项
答案
more information。
解析
根据题干中的信息词concern和call the drug company定位到最后一点,可知你在用新药时,要向医生询问清楚有关药物的情况,让药剂师以专家顾问的身份来解决你对药物及其副作用的额’外疑问,你也可以给制药公司打免费电话询问更多的信息,或是登录其网站,由此可得答案。
转载请注明原文地址:https://kaotiyun.com/show/aN7K777K
0
大学英语六级
相关试题推荐
A、Howtobuyorsellshares.B、Basicknowledgeofstockmarket.C、Thestockmarketislikegambling.D、Investingmoneyinthest
A、Takeapainreliever.B、Letthecutdryout.C、Keepthecutclosed.D、Gotoadoctor.CW给M的建议是:Gogetyourselfabandage.(给你自
InthefirstyearorsoofWebbusiness,mostoftheactionhasrevolvedaroundeffortstotaptheconsumermarket.Morerecentl
InthefirstyearorsoofWebbusiness,mostoftheactionhasrevolvedaroundeffortstotaptheconsumermarket.Morerecentl
Areorganicallygrownfoodsthebestfoodchoices?Theadvantagesclaimedforsuchfoodsoverconventionallygrownandmarketed
Areorganicallygrownfoodsthebestfoodchoices?Theadvantagesclaimedforsuchfoodsoverconventionallygrownandmarketed
Areorganicallygrownfoodsthebestfoodchoices?Theadvantagesclaimedforsuchfoodsoverconventionallygrownandmarketed
Marketingistheprocessbywhichgoodsaresoldandpurchased.Thatprocessmaybeasimpleactofexchangeoranintricate,se
Marketingistheprocessbywhichgoodsaresoldandpurchased.Thatprocessmaybeasimpleactofexchangeoranintricate,se
随机试题
2014年3月2日,甲、乙离婚并分割了共同财产。2015年3月8日。甲发现乙在离婚时将属于夫妻共有的40万元存款转移到了乙兄的银行账户中,遂向人民法院起诉,请求分割该40万元存款。本案的诉讼时效期间起算日为
本节主要写了什么内容?本节体现战斗结果的是哪一句?
2018年7月8日14时47分许,刘甲驾驶车辆(该车辆车主是刘乙)沿大学路由西向东行驶至文化商城街口处时,由于被对向公交车上喷涂的广告女郎吸引侧目,而与由南向北李某驾驶的电动自行车相撞,刘甲忙乱中驶入对向车道又与由东向西张某驾驶的公交车相撞,造成车辆上的女
在大、中城市和小城市,自行车最远的出行距离应分别按()km和()km计算。
采用重点抽查法审查施工图预算,审查重点有()。
2007年2月2日甲与乙签订了一个合同,合同中约定甲将自己唯一的挖掘机租给乙,租期为2007年3月1日至2008年3月1日。但是在2007年2月25日甲却将此挖掘机租给了丙,租期为2007年2月25日至2007年6月25日,则()。
【背景资料】某机场原跑道长2700m、宽60m,可供B737以下机型使用。为了满足B747—200机型的使用,2010年在原跑道的一端延长了500m,其道面分块尺寸为5m×5m。之后在组织验收时,监理单位对跑道延长段道面平整度采用了如下的检查方法
如果进出口货物的成交价格是以外币计价的,海关应当采用()所适用的计征汇率折合为人民币计算完税价格。
lease
A、HeisallrightB、Hefeelsworried.C、Heisill.D、Hefeelsbetternow.C题目问格林先生状况如何。从女士的建议“卧床休息几天就会好转”中,不难推测出格林先生可能生病了。因此C项是正
最新回复
(
0
)